Regeneron (REGN) reported $3.88 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 2.5%. EPS of $11.44 for the same period compares to $12.07 a year

Red River Bancshares (RRBI) reported $33.19 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 15.7%. EPS of $1.73 for the same period compares to

Oshkosh Corporation OSK reported fourth-quarter 2025 adjusted earnings of $2.26 per share, which missed the Zacks Consensus Estimate of $2.33. The bottom line was also below $2.58 recorded in the

The Zacks Security and Safety Services industry is well-positioned to benefit from strong demand for products and solutions with growing awareness about the security and safety of people and

Increased volatility, supportive U.S. economic policies under President Donald Trump, higher acceptance of digital assets, continued efforts of the exchange players to go beyond only trading

Stryker Corporation SYK reported fourth-quarter 2025 adjusted earnings per share (EPS) of $4.47, which beat the Zacks Consensus Estimate of $4.40 by 1.6%. The bottom line also improved 11.5% year

Regeneron Pharmaceuticals, Inc. REGN reported fourth-quarter 2025 adjusted earnings per share (EPS) of $11.44, which comfortably beat the Zacks Consensus Estimate of $10.56. However, the bottom line

Summit Therapeutics SMMT announced that the FDA has accepted its biologics license application (BLA) seeking approval for ivonescimab plus chemotherapy in patients with EGFR-mutated, locally

As global defense spending increases amid ongoing geopolitical tensions, companies such as AeroVironment, Inc. AVAV and L3Harris Technologies, Inc. LHX are drawing greater investor interest. Rising